{"id":6172,"date":"2026-01-11T15:52:34","date_gmt":"2026-01-11T15:52:34","guid":{"rendered":"https:\/\/www.enyopharma.com\/fr\/?p=6172"},"modified":"2026-01-15T15:53:41","modified_gmt":"2026-01-15T15:53:41","slug":"j-p-morgan-week-a-san-francisco","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/j-p-morgan-week-a-san-francisco\/","title":{"rendered":"J.P.\u00a0Morgan week \u00e0 San Francisco"},"content":{"rendered":"\n
11-15 Janvier 2026
San Francisco, Etats-Unis<\/p>\n\n\n\n
51ÂÜÀò sera \u00e0 San Francisco durant la “J.P.\u00a0Morgan week” pour rencontrer les leaders industriels, entreprises innovantes et investisseurs et pr\u00e9senter ses avanc\u00e9s dans le d\u00e9veloppement de Vonafexor dans les maladies r\u00e9nales.<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
11-15 Janvier 2026
San Francisco, Etats-Unis<\/p>\n
51ÂÜÀò sera \u00e0 San Francisco durant la “J.P.\u00a0Morgan week” pour rencontrer les leaders industriels, entreprises innovantes et investisseurs et pr\u00e9senter ses avanc\u00e9s dans le d\u00e9veloppement de Vonafexor dans les maladies r\u00e9nales.<\/p>\n<\/p>\n
Lire la suite »<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-6172","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"adm-cdubreuil","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/adm-cdubreuil\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"11-15 Janvier 2026San Francisco, Etats-Unis 51ÂÜÀò sera \u00e0 San Francisco durant la “J.P.\u00a0Morgan week” pour rencontrer les leaders industriels, entreprises innovantes et investisseurs et pr\u00e9senter ses avanc\u00e9s dans le d\u00e9veloppement de Vonafexor dans les maladies r\u00e9nales. Lire la suite »","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/6172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=6172"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/6172\/revisions"}],"predecessor-version":[{"id":6175,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/6172\/revisions\/6175"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=6172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=6172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=6172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}